These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood. Desser L; Holomanova D; Zavadova E; Pavelka K; Mohr T; Herbacek I Cancer Chemother Pharmacol; 2001 Jul; 47 Suppl():S10-5. PubMed ID: 11561866 [TBL] [Abstract][Full Text] [Related]
7. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease. Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549 [TBL] [Abstract][Full Text] [Related]
8. Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. Narita M; Holtzman DM; Schwartz AL; Bu G J Neurochem; 1997 Nov; 69(5):1904-11. PubMed ID: 9349534 [TBL] [Abstract][Full Text] [Related]
12. In vivo metabolism of inter-alpha-trypsin inhibitor and its proteinase complexes: evidence for proteinase transfer to alpha 2-macroglobulin and alpha 1-proteinase inhibitor. Pratt CW; Pizzo SV Arch Biochem Biophys; 1986 Aug; 248(2):587-96. PubMed ID: 2427028 [TBL] [Abstract][Full Text] [Related]
13. Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. Mackic JB; Stins M; McComb JG; Calero M; Ghiso J; Kim KS; Yan SD; Stern D; Schmidt AM; Frangione B; Zlokovic BV J Clin Invest; 1998 Aug; 102(4):734-43. PubMed ID: 9710442 [TBL] [Abstract][Full Text] [Related]
14. Cerebral clearance of human amyloid-beta peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes. Ito S; Ohtsuki S; Kamiie J; Nezu Y; Terasaki T J Neurochem; 2007 Dec; 103(6):2482-90. PubMed ID: 17908238 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of inflammatory proteinase, medullasin, by alpha 2-macroglobulin and ovomacroglobulin. Ikai A; Nakashima M; Aoki Y Biochem Biophys Res Commun; 1989 Feb; 158(3):831-6. PubMed ID: 2465765 [TBL] [Abstract][Full Text] [Related]
17. Alpha2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons. Du Y; Bales KR; Dodel RC; Liu X; Glinn MA; Horn JW; Little SP; Paul SM J Neurochem; 1998 Mar; 70(3):1182-8. PubMed ID: 9489740 [TBL] [Abstract][Full Text] [Related]
18. Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation. Hughes SR; Khorkova O; Goyal S; Knaeblein J; Heroux J; Riedel NG; Sahasrabudhe S Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3275-80. PubMed ID: 9501253 [TBL] [Abstract][Full Text] [Related]
19. Alpha 2-macroglobulin protects some of the protein constituents of dialysis-associated amyloidosis from protease degradation. Gouin-Charnet A; Mourad G; Argilés A Biochem Biophys Res Commun; 1997 Feb; 231(1):48-51. PubMed ID: 9070217 [TBL] [Abstract][Full Text] [Related]
20. Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease. Sadowski MJ; Pankiewicz J; Scholtzova H; Mehta PD; Prelli F; Quartermain D; Wisniewski T Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18787-92. PubMed ID: 17116874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]